Terry-Ann Burrell, a financial industry veteran, is Chief Financial Officer of Beam. Prior to Beam, Ms. Burrell spent 11 years with J.P. Morgan, most recently as a Managing Director in the healthcare investment banking group. There, she had broad coverage across the biotechnology and pharmaceutical industries, helping to execute over $10 billion in equity and equity linked financings and more than $50 billion in M&A transactions. She was instrumental in advising clients on transaction considerations, including strategic rationale, valuation and structuring, and engaged with more than 100 companies during her tenure. Prior to J.P. Morgan, Ms. Burrell worked in equity research at Citigroup, where she covered specialty pharmaceuticals and generics.Ms. Burrell holds an MBA from New York University Leonard N. Stern School of Business and a B.A. from Harvard University.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Beam Therapeutics | Chief Financial Officer | — | — | Detail |